Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O D Howes

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Psychological Medicine|September 16, 2016
Salience attribution and its relationship to cannabis-induced psychotic symptomsM A P Bloomfield, E Mouchlianitis, C J A Morgan, et al.
Psychological Medicine|March 24, 2011
Striatal dopamine synthesis capacity in twins discordant for schizophreniaP Shotbolt, P R Stokes, S F Owens, et al.
Molecular Psychiatry|December 2, 2009
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosisP Fusar-Poli, O D Howes, P Allen, et al.
Acta Psychiatrica Scandinavica|October 27, 2017
Antipsychotic plasma levels in the assessment of poor treatment response in schizophreniaR McCutcheon, K Beck, E D'Ambrosio, et al.
Psychological Medicine|October 2, 2015
Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET studyE Kim, O D Howes, J W Park, et al.
Translational Psychiatry|October 4, 2017
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosisT Winton-Brown, A Schmidt, J P Roiser, et al.
Translational Psychiatry|September 2, 2018
Correction: Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosisT Winton-Brown, A Schmidt, J P Roiser, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
Psychological Medicine|September 9, 2016
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychosesJ Lally, O Ajnakina, M Di Forti, et al.
Psychological Medicine|April 12, 2017
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictorsA Demjaha, J M Lappin, D Stahl, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Psychological Medicine|September 16, 2016
Salience attribution and its relationship to cannabis-induced psychotic symptomsM A P Bloomfield, E Mouchlianitis, C J A Morgan, et al.
Psychological Medicine|March 24, 2011
Striatal dopamine synthesis capacity in twins discordant for schizophreniaP Shotbolt, P R Stokes, S F Owens, et al.
Molecular Psychiatry|December 2, 2009
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosisP Fusar-Poli, O D Howes, P Allen, et al.
Acta Psychiatrica Scandinavica|October 27, 2017
Antipsychotic plasma levels in the assessment of poor treatment response in schizophreniaR McCutcheon, K Beck, E D'Ambrosio, et al.
Psychological Medicine|October 2, 2015
Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET studyE Kim, O D Howes, J W Park, et al.
Translational Psychiatry|October 4, 2017
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosisT Winton-Brown, A Schmidt, J P Roiser, et al.
Translational Psychiatry|September 2, 2018
Correction: Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosisT Winton-Brown, A Schmidt, J P Roiser, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
Psychological Medicine|September 9, 2016
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychosesJ Lally, O Ajnakina, M Di Forti, et al.
Psychological Medicine|April 12, 2017
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictorsA Demjaha, J M Lappin, D Stahl, et al.
Pageof 3